| 000 | 04920cam a22003858i 4500 | ||
|---|---|---|---|
| 999 |
_c233273 _d233273 |
||
| 001 | 18533282 | ||
| 003 | Nust | ||
| 005 | 20170306121147.0 | ||
| 008 | 150306s2015 nju b 001 0 eng c | ||
| 010 | _a 2015007931 | ||
| 020 | _a978-0-07-163572-1 | ||
| 040 |
_aWaSeSS/DLC _beng _cASAB _erda |
||
| 042 | _apcc | ||
| 050 | 0 | 0 |
_aQH588.S83 _bS7473 2015 |
| 082 | 0 | 0 |
_a616.02/774 _223 |
| 245 | 0 | 0 |
_astem cells in regenerative medicine : _bbasic and applications _cKaushik D. Deb & satish M. Totey |
| 263 | _a1506 | ||
| 264 | 1 |
_aHoboken, NJ : _bJohn Wiley & Sons, Ltd, _c2015. |
|
| 300 | _a685 P | ||
| 336 |
_atext _2rdacontent |
||
| 337 |
_aunmediated _2rdamedia |
||
| 338 |
_avolume _2rdacarrier |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 0 | _aTherapeutic stem cells answer a strategic breakthrough need of healthcare / Alain Vertes -- Ethical considerations on the research and business of stem cells / Ljiljana Minwalla -- Projected growth of the worldwide stem cell market / Ed Field -- Cell therapy manufacturing: identifying and meeting demand / Jessica Carmen, David A. Brindley, Natasha L. Davie and David Smith -- The history of stem cell transplantation / Hilliard M. Lazarus and Stan Gerson -- Regulatory and intellectual property considerations for therapeutic human stem cell-based regenerative medicine product development: a U.S. perspective / Michael Mendicino and Darin Weber -- The regulation of stem cells in the UK and EU / Alex Denoon, Julian Hitchcock and James Lawford Davies -- The business of stem cell research tools / Erik Miljan -- Stem cell-derived cardiomyocytes and hepatocytes as tools for drug development and screening applications / Kate Camerona, Howard Marriage, David Haya and Claire Medine -- Stem cell tools for compound development / Tom Novak -- Stem cell origin of cancer: prospects for functional therapeutics and regenerative medicine / Vinagolu K. Rajasekhar -- The market of stem cell medicines for domestic and high value animals / Bob J. Harmann -- Stem cells veterinary medicines: a conceptual approach / John Peroni and Lindsey Boone -- Stem cells in veterinary medicines: a practical approach / Bob J. Harmann -- Stem cell veterinary medicines as success signals towards human stem cell therapeutics / Alain Vertes -- Animal models in regenerative medicine / Andrew N. Bubak, John D. Elsworth and John R. Sladek, Jr. -- Stem cell characterization: a guide to stem cell types, technologies, and future applications / Justin Lo Re, Rezma Shrestha and Leonard Sciorra -- Stem cell value chains / Judy Muller-Cohn, Paul Diaz and Rolf Muller -- Stem cell culture processes / Ravali Raju, Shikha Sharma and Wei-Shou Hu -- Indication transformation maps and the challenge of live cells delivery / Bob Deans and Lee Babiss -- Delivery and targeting of therapeutic cells / Paul Lin, Arnold I. Caplan and Erkki Ruoshlati -- Hematopoietic stem cells / Steve Wolpe and Lynnet Koh -- MSCs: the new medicince / Arnold Caplan -- Innovation and commercialization of induced pluripotent stem cells / Shintaro Sengoku -- Embryonic stem cells / Rachel Eiges, Benjamin E. Reubinoff and Charles Irving -- Allogeneic versus autologous stem cell transplantation in regenerative medicine / Kathy Trzaska-Accurso and Pranela Rameshwar -- Clinical immunological barriers to regenerative medicine: do they matter? / Cristina Trento and Francesco Dazzi -- Challenges in the clinical development of stem cells / John Caulfield -- Pricing and reimbursement of regenerative medicines / Nathan Dowden -- The role of patient advocacy in the clinical translation of regenerative medicine / Bernard Siegel and Alan Jakimo -- Financing strategies for regenerative medicine start-ups / Carol Julie Walton, Lee Buckler and Gregory A. Bonfiglio -- Strategic alliances, mergers and acquisitions in regenerative medicine / Nafees N. Malik, Timothy E. Allsopp and Devyn M. Smith -- History of monoclonal antibodies and lessons for the development of stem cell therapeutics / Alain Vertes and Nathan Dowden -- Deployment of stem cell technologies in industry and healthcare/ Alain Vertes. | |
| 650 | 0 | _aStem cells. | |
| 650 | 0 | _aRegenerative medicine. | |
| 700 | 1 |
_aVertes, Alain A., _eeditor. |
|
| 700 | 1 |
_aQureshi, Nasib, _eeditor. |
|
| 700 | 1 |
_aCaplan, Arnold I., _eeditor. |
|
| 700 | 1 |
_aBabiss, Lee Edward, _d1956- _eeditor. |
|
| 776 | 0 | 8 |
_iOnline version: _tStem cells in regenerative medicine _dHoboken, NJ : John Wiley & Sons, Ltd, 2015 _z9781118846209 _w(DLC) 2015012590 |
| 906 |
_a7 _bcbc _corignew _d1 _eecip _f20 _gy-gencatlg |
||
| 942 |
_2ddc _cBK |
||